BioCentury | Aug 30, 2004
Finance

Ebb & Flow

...current investors." Existing investors who participated in the financing included HealthCare Ventures; Advent Venture Partners; Merrill Lynch Ventures...
BioCentury | Aug 24, 2004
Financial News

Metaphore raises $40.2M

...raised $40.2 million in a series D round. Investors included HealthCare Ventures; Advent Venture Partners; Merrill Lynch Ventures...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...cash. Principal stockholders include Bay City Capital (12.1% prior to the offering); Rho Ventures (11.1%); Merrill Lynch Ventures...
BioCentury | Sep 15, 2003
Finance

Ebb & Flow

...around $220 million. The company boasts blue chip VCs, including Schroder Ventures, which owns 12.9%; Merrill Lynch Ventures...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...EPI-12323 in both asthma in COPD. Other investors were Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures...
BioCentury | Jun 9, 2003
Financial News

EpiGenesis raises $23 million

...A round led by Care Capital. Other investors included Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures...
BioCentury | Jul 15, 2002
Finance

Ebb & Flow

...million deal for cardiovascular company MetaPhore was led by HealthCare Ventures; Advent Venture Partners; and Merrill Lynch Ventures...
BioCentury | Jul 11, 2002
Financial News

MetaPhore raises $30 million

...million in a series C round led by HealthCare Ventures VI; Advent Venture Partners; and Merrill Lynch Ventures...
BioCentury | Apr 22, 2002
Finance

Ebb & Flow

...Other investors included A.M. Pappas; Global Biomedical Partners; AFB Fund; Venrock Associates; BancBoston Ventures; and Merrill Lynch Ventures...
BioCentury | Apr 16, 2002
Financial News

Syntonix raises $35.8 million

...Partners. Other investors included A.M. Pappas; Global Biomedical Partners; AFB Fund; Venrock Associates; BancBoston Ventures; Merrill Lynch Ventures...
Items per page:
1 - 10 of 17
BioCentury | Aug 30, 2004
Finance

Ebb & Flow

...current investors." Existing investors who participated in the financing included HealthCare Ventures; Advent Venture Partners; Merrill Lynch Ventures...
BioCentury | Aug 24, 2004
Financial News

Metaphore raises $40.2M

...raised $40.2 million in a series D round. Investors included HealthCare Ventures; Advent Venture Partners; Merrill Lynch Ventures...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...cash. Principal stockholders include Bay City Capital (12.1% prior to the offering); Rho Ventures (11.1%); Merrill Lynch Ventures...
BioCentury | Sep 15, 2003
Finance

Ebb & Flow

...around $220 million. The company boasts blue chip VCs, including Schroder Ventures, which owns 12.9%; Merrill Lynch Ventures...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...EPI-12323 in both asthma in COPD. Other investors were Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures...
BioCentury | Jun 9, 2003
Financial News

EpiGenesis raises $23 million

...A round led by Care Capital. Other investors included Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures...
BioCentury | Jul 15, 2002
Finance

Ebb & Flow

...million deal for cardiovascular company MetaPhore was led by HealthCare Ventures; Advent Venture Partners; and Merrill Lynch Ventures...
BioCentury | Jul 11, 2002
Financial News

MetaPhore raises $30 million

...million in a series C round led by HealthCare Ventures VI; Advent Venture Partners; and Merrill Lynch Ventures...
BioCentury | Apr 22, 2002
Finance

Ebb & Flow

...Other investors included A.M. Pappas; Global Biomedical Partners; AFB Fund; Venrock Associates; BancBoston Ventures; and Merrill Lynch Ventures...
BioCentury | Apr 16, 2002
Financial News

Syntonix raises $35.8 million

...Partners. Other investors included A.M. Pappas; Global Biomedical Partners; AFB Fund; Venrock Associates; BancBoston Ventures; Merrill Lynch Ventures...
Items per page:
1 - 10 of 17